ONL Therapeutics logo

ONL Therapeutics

Ann Arbor, MI

ONL Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops drugs for the treatment of serious, vision-threatening retinal diseases, and conditions including retinal detachment and wet and dry forms of age-related macular degeneration. ONL Therapeutics serves patients in the United States.

onltherapeutics.com

Company Details

Founded

2014

Employees

Between 10 - 50 employees

Raised

$147,937,920

Headquarters Location

Ann Arbor, MI

Public

No

Acquired

No

CEO

David EspositoDavid Esposito

Founders

David Zacks
David Zacks

Company Collections

These are collections ONL Therapeutics is a part of. Click on the collection name to view similar companies.

ONL Therapeutics Headquarters Location

1600 Huron Pky building 520 Second Floor, Ann Arbor, MI 48109

Total Amount Raised: $147,937,920

ONL Therapeutics Funding Rounds

  • Series D

    $65,000,000

    Series D Investors

    Johnson & Johnson Innovation
    Bios Partners
    Novartis Venture Fund
    Visionary Ventures
  • Series Unknown

    $9,999,948

  • Series C

    $15,000,000

    Series C Investors

    Alpine Visionary
    Bios Partners
    Mayewell Capital
    Visionary Venture Fund
    ExSight Ventures
    PSQ Capital
    Biosciences Research and Commercialization Center
    Michigan Capital Network
    Kaitai Capital
    Capital Community Angel Investors
    Johnson & Johnson Robotics and Digital Solutions
    MINTS
  • Series B

    $46,900,000

    Series B Investors

    Bios Partners
    Johnson & Johnson Innovation
    ExSight Ventures
    Capital Community Angel Investors
    Biosciences Research and Commercialization Center
    Kaitai Capital
    Grand Angels
    MINTS
    InFocus Capital Partners
    PSQ Capital
  • Convertible Note

    $3,000,000

    Convertible Note Investors

    Invest Michigan
    Capital Community Angel Investors
    InFocus Capital Partners
  • Series A

    $4,250,000

    Series A Investors

    Novartis
    Capital Community Angel Investors
    InvestMichigan
    Biosciences Research and Commercialization Center
    MINTS
    Hestia Investments
    ExSight Ventures
  • Grant

    $1,000,000

    Grant Investors

    National Institutes of Health (NIH)
  • Debt Financing

    $916,161

  • Grant

    $1,370,000

  • Seed

    $501,810

    Seed Investors

    Capital Community Angel Investors
Funding info provided by Diffbot.

ONL Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ONL Therapeutics.

Recent reviews